Dolores Shoback, MD

Title(s)Professor, Medicine
SchoolSchool of Medicine
Address513 Parnassus Avenue, HSW, #210
San Francisco CA 94143
Phone415-750-2089
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Johns HopkinsM.D.1977School of Medicine

    Collapse Overview 
    Collapse Overview
    Dr. Dolores Shoback cares for patients with a variety of disorders related to the endocrine system, focusing particularly on metabolic bone disease, parathyroid disorders and osteoporosis. She also directs UCSF's physician training program in diabetes, endocrinology and metabolism.

    Shoback's research interests include metabolic bone disease, the calcium-sensing receptor and parathyroid hormone.

    Shoback completed her undergraduate studies at the University of Pennsylvania. She earned her medical degree from the Johns Hopkins School of Medicine and completed a residency in internal medicine at the Johns Hopkins Hospital. She completed a fellowship in endocrinology at Brigham and Women's Hospital.

    Collapse Research 
    Collapse Research Activities and Funding
    Novel Combination Therapy for Osteoporosis in Men
    NIH I01CX001514Jul 1, 2019 - Jun 30, 2024
    Role: Principal Investigator
    Mechanisms Underlying Hormonal Regulation of Fracture Repair
    NIH IP1BX001599Jan 1, 2012 - Dec 31, 2015
    Role: Co-Principal Investigator
    Conditional Knockout of Calcium Receptors in Bone Cells
    NIH R01AR055588Jul 10, 2009 - Apr 30, 2016
    Role: Principal Investigator
    DESENSITIZATION AND DOWN REGULATION OF CALCIUM RECEPTORS
    NIH R01DK055846Jul 1, 1999 - Oct 31, 2004
    Role: Principal Investigator
    REGULATION OF INTRACELLULAR CALCIUM IN PARATHYROID CELLS
    NIH R01DK043400Jun 1, 1991 - Mar 31, 2000
    Role: Principal Investigator
    REGULATION OF PARATHORMONE SECRETION IN DISPERSED CELLS
    NIH R29DK039594Apr 1, 1988 - Dec 31, 1991
    Role: Principal Investigator
    REGULATION OF PARATHORMONE SECRETION IN DISPERSED CELLS
    NIH R23DK036919Apr 1, 1986 - Mar 31, 1989
    Role: Principal Investigator
    Diabetes, Endocrinology & Metabolism Training Grant
    NIH T32DK007418Jul 1, 1981 - Jun 30, 2022
    Role: Co-Principal Investigator
    MULTIPURPOSE ARTHRITIS AND MUSCULOSKELETAL DISEASES CTR
    NIH P60AR020684Sep 15, 1977 - Dec 31, 2003
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Academic Senate

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Efficacy and Safety of TransCon PTH in Adults with Hypoparathyroidism: 52-Week Results From the Phase 3 PaTHway Trial. J Clin Endocrinol Metab. 2024 Oct 08. Clarke BL, Khan AA, Rubin MR, Schwarz P, Vokes T, Shoback DM, Gagnon C, Palermo A, Abbott LG, Hofbauer LC, Kohlmeier L, Cetani F, Pihl S, An X, Smith AR, Lai B, Ukena J, Sibley CT, Shu AD, Rejnmark L. PMID: 39376010.
      View in: PubMed   Mentions:    Fields:    
    2. Palopegteriparatide Treatment Improves Renal Function in Adults with Chronic Hypoparathyroidism: 1-Year Results from the Phase 3 PaTHway Trial. Adv Ther. 2024 Jun; 41(6):2500-2518. Rejnmark L, Gosmanova EO, Khan AA, Makita N, Imanishi Y, Takeuchi Y, Sprague S, Shoback DM, Kohlmeier L, Rubin MR, Palermo A, Schwarz P, Gagnon C, Tsourdi E, Zhao C, Makara MA, Ominsky MS, Lai B, Ukena J, Sibley CT, Shu AD. PMID: 38691316; PMCID: PMC11133178.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    3. Cinacalcet increases renal calcium excretion in PTHrP-mediated hypercalcemia: a case report. BMC Endocr Disord. 2023 Jun 16; 23(1):133. Faiq S, Lavelle K, Hu T, Shoback D, Ku G. PMID: 37328745; PMCID: PMC10273565.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Long-Term Safety and Efficacy of Recombinant Human Parathyroid Hormone (1-84) in Adults With Chronic Hypoparathyroidism. J Endocr Soc. 2023 Mar 06; 7(5):bvad043. Watts NB, Bilezikian JP, Bone HG, Clarke BL, Denham D, Levine MA, Mannstadt M, Peacock M, Rothman JG, Vokes TJ, Warren ML, Yin S, Sherry N, Shoback DM. PMID: 37091306; PMCID: PMC10119703.
      View in: PubMed   Mentions: 1  
    5. Orlo H. Clark, MD (1941-2022). Thyroid. 2023 04; 33(4):395-401. Shen WT, Kebebew E, Shoback D, Liu C, Gosnell JE, Caron NR. PMID: 36719769.
      View in: PubMed   Mentions:    Fields:    
    6. Etiology and Pathophysiology of Hypoparathyroidism: A Narrative Review. J Bone Miner Res. 2022 12; 37(12):2586-2601. Pasieka JL, Wentworth K, Yeo CT, Cremers S, Dempster D, Fukumoto S, Goswami R, Houillier P, Levine MA, Pasternak JD, Perrier ND, Sitges-Serra A, Shoback DM. PMID: 36153665; PMCID: PMC10364481.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    7. Evaluation and Management of Hypoparathyroidism Summary Statement and Guidelines from the Second International Workshop. J Bone Miner Res. 2022 12; 37(12):2568-2585. Khan AA, Bilezikian JP, Brandi ML, Clarke BL, Gittoes NJ, Pasieka JL, Rejnmark L, Shoback DM, Potts JT, Guyatt GH, Mannstadt M. PMID: 36054621.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    8. Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial. J Bone Miner Res. 2023 01; 38(1):14-25. Khan AA, Rubin MR, Schwarz P, Vokes T, Shoback DM, Gagnon C, Palermo A, Marcocci C, Clarke BL, Abbott LG, Hofbauer LC, Kohlmeier L, Pihl S, An X, Eng WF, Smith AR, Ukena J, Sibley CT, Shu AD, Rejnmark L. PMID: 36271471; PMCID: PMC10099823.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    9. Bone marrow adipose tissue composition and glycemic improvements after gastric bypass surgery. Bone Rep. 2022 Dec; 17:101596. Kim TY, Schwartz AV, Li X, Xu K, Kazakia GJ, Grunfeld C, Nissenson RA, Shoback DM, Schafer AL. PMID: 35734226; PMCID: PMC9207612.
      View in: PubMed   Mentions: 2  
    10. Low cumulative disease activity is associated with higher bone mineral density in a majority Latinx and Asian US rheumatoid arthritis cohort. Semin Arthritis Rheum. 2022 04; 53:151972. Wysham KD, Shofer J, Lui G, Trupin L, Andrews JS, Black DM, Graf J, Shoback DM, Katz PP. PMID: 35152085; PMCID: PMC8963706.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    11. Risk of Fracture Among Older Adults With Primary Hyperparathyroidism Receiving Parathyroidectomy vs Nonoperative Management. JAMA Intern Med. 2022 01 01; 182(1):10-18. Seib CD, Meng T, Suh I, Harris AHS, Covinsky KE, Shoback DM, Trickey AW, Kebebew E, Tamura MK. PMID: 34842909; PMCID: PMC8630642.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    12. Sporadic Primary Hyperparathyroidism. Endocrinol Metab Clin North Am. 2021 12; 50(4):609-628. Kim SJ, Shoback DM. PMID: 34774237.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    13. The PARADIGHM (physicians advancing disease knowledge in hypoparathyroidism) registry for patients with chronic hypoparathyroidism: study protocol and interim baseline patient characteristics. BMC Endocr Disord. 2021 Nov 20; 21(1):232. Gittoes N, Rejnmark L, Ing SW, Brandi ML, Björnsdottir S, Hahner S, Hofbauer LC, Houillier P, Khan AA, Levine MA, Mannstadt M, Shoback DM, Vokes TJ, Zhang P, Marelli C, Germak J, Clarke BL. PMID: 34801015; PMCID: PMC8606089.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    14. A Distinction Without a Difference-Does It Matter Whether Fractures Are Nontraumatic or Traumatic? JAMA Intern Med. 2021 08 01; 181(8):1063-1064. Schafer AL, Shoback DM. PMID: 34096970.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    15. Osteoporosis and fractures in rheumatoid arthritis. Curr Opin Rheumatol. 2021 05 01; 33(3):270-276. Wysham KD, Baker JF, Shoback DM. PMID: 33651725.
      View in: PubMed   Mentions: 24  Translation:Humans
    16. Bone age is not just for kids. Elife. 2021 03 02; 10. Cauley JA, Shoback DM. PMID: 33650970; PMCID: PMC7924936.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Sex differences in frailty and its association with low bone mineral density in rheumatoid arthritis. Bone Rep. 2020 Jun; 12:100284. Wysham KD, Shoback DM, Andrews JS, Katz PP. PMID: 32509932; PMCID: PMC7264043.
      View in: PubMed   Mentions: 11  
    18. A bridge too far? Attempting to bridge the treatment gap in osteoporosis. Endocrine. 2020 08; 69(2):241-243. Clarke BL, Shoback DM. PMID: 32441027; PMCID: PMC8832363.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. PTH hypersecretion triggered by a GABAB1 and Ca2+-sensing receptor heterocomplex in hyperparathyroidism. Nat Metab. 2020 03; 2(3):243-255. Chang W, Tu CL, Jean-Alphonse FG, Herberger A, Cheng Z, Hwong J, Ho H, Li A, Wang D, Liu H, White AD, Suh I, Shen W, Duh QY, Khanafshar E, Shoback DM, Xiao K, Vilardaga JP. PMID: 32694772; PMCID: PMC7377265.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimals
    20. Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Guideline Update. J Clin Endocrinol Metab. 2020 03 01; 105(3). Shoback D, Rosen CJ, Black DM, Cheung AM, Murad MH, Eastell R. PMID: 32068863.
      View in: PubMed   Mentions: 105     Fields:    Translation:Humans
    21. Increases in PYY and uncoupling of bone turnover are associated with loss of bone mass after gastric bypass surgery. Bone. 2020 02; 131:115115. Kim TY, Shoback DM, Black DM, Rogers SJ, Stewart L, Carter JT, Posselt AM, King NJ, Schafer AL. PMID: 31689523; PMCID: PMC6930344.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    22. Safety and Efficacy of 5 Years of Treatment With Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism. J Clin Endocrinol Metab. 2019 11 01; 104(11):5136-5147. Mannstadt M, Clarke BL, Bilezikian JP, Bone H, Denham D, Levine MA, Peacock M, Rothman J, Shoback DM, Warren ML, Watts NB, Lee HM, Sherry N, Vokes TJ. PMID: 31369089; PMCID: PMC6760337.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    23. Calcium-Sensing Receptors in Chondrocytes and Osteoblasts Are Required for Callus Maturation and Fracture Healing in Mice. J Bone Miner Res. 2020 01; 35(1):143-154. Cheng Z, Li A, Tu CL, Maria CS, Szeto N, Herberger A, Chen TH, Song F, Wang J, Liu X, Shoback DM, Chang W. PMID: 31498905; PMCID: PMC7700777.
      View in: PubMed   Mentions: 13     Fields:    Translation:AnimalsCells
    24. New Frontiers in Osteoporosis Therapy. Annu Rev Med. 2020 01 27; 71:277-288. Cheng C, Wentworth K, Shoback DM. PMID: 31509477.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    25. Applying the Guidelines for Primary Hyperparathyroidism: The Path Not Taken. JAMA Intern Med. 2019 Sep 01; 179(9):1227-1229. Wentworth K, Shoback D. PMID: 31305872.
      View in: PubMed   Mentions: 1     Fields:    
    26. Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline. J Clin Endocrinol Metab. 2019 05 01; 104(5):1595-1622. Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D. PMID: 30907953.
      View in: PubMed   Mentions: 241     Fields:    Translation:Humans
    27. Changes in Lean Mass, Absolute and Relative Muscle Strength, and Physical Performance After Gastric Bypass Surgery. J Clin Endocrinol Metab. 2019 03 01; 104(3):711-720. Alba DL, Wu L, Cawthon PM, Mulligan K, Lang T, Patel S, King NJ, Carter JT, Rogers SJ, Posselt AM, Stewart L, Shoback DM, Schafer AL. PMID: 30657952; PMCID: PMC6339456.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    28. Mechanisms Underlying Normal Fracture Healing and Risk Factors for Delayed Healing. Curr Osteoporos Rep. 2019 02; 17(1):36-47. Cheng C, Shoback D. PMID: 30671884.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimals
    29. Rapid onset of hypercalcemia from high-grade lymphoma in the setting of HIV-related immune reconstitution inflammatory syndrome. Bone Rep. 2019 Jun; 10:100194. Kim SJ, Peluso MJ, Wang Y, Bikle D, Shoback D, Kim S. PMID: 30627599; PMCID: PMC6319307.
      View in: PubMed   Mentions: 2  
    30. Conventional Treatment of Hypoparathyroidism. Endocrinol Metab Clin North Am. 2018 12; 47(4):889-900. Babey M, Brandi ML, Shoback D. PMID: 30390820.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    31. Familial hypocalciuric hypercalcemia and related disorders. Best Pract Res Clin Endocrinol Metab. 2018 10; 32(5):609-619. Lee JY, Shoback DM. PMID: 30449544; PMCID: PMC6767927.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    32. Association of High Anti-Cyclic Citrullinated Peptide Seropositivity and Lean Mass Index With Low Bone Mineral Density in Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2018 07; 70(7):961-969. Wysham KD, Shoback DM, Imboden JB, Katz PP. PMID: 29106028; PMCID: PMC5936473.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    33. Effects of Gastric Bypass Surgery on Bone Mass and Microarchitecture Occur Early and Particularly Impact Postmenopausal Women. J Bone Miner Res. 2018 06; 33(6):975-986. Schafer AL, Kazakia GJ, Vittinghoff E, Stewart L, Rogers SJ, Kim TY, Carter JT, Posselt AM, Pasco C, Shoback DM, Black DM. PMID: 29281126; PMCID: PMC6002877.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    34. Recombinant Human Parathyroid Hormone Effect on Health-Related Quality of Life in Adults With Chronic Hypoparathyroidism. J Clin Endocrinol Metab. 2018 02 01; 103(2):722-731. Vokes TJ, Mannstadt M, Levine MA, Clarke BL, Lakatos P, Chen K, Piccolo R, Krasner A, Shoback DM, Bilezikian JP. PMID: 29099947; PMCID: PMC6458961.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    35. Hypoparathyroidism. Nat Rev Dis Primers. 2017 Oct 05; 3:17080. Mannstadt M, Bilezikian JP, Thakker RV, Hannan FM, Clarke BL, Rejnmark L, Mitchell DM, Vokes TJ, Winer KK, Shoback DM. PMID: 28980621.
      View in: PubMed   Mentions: 26     Fields:    
    36. Diagnosis and Management of Osteopetrosis: Consensus Guidelines From the Osteopetrosis Working Group. J Clin Endocrinol Metab. 2017 09 01; 102(9):3111-3123. Wu CC, Econs MJ, DiMeglio LA, Insogna KL, Levine MA, Orchard PJ, Miller WP, Petryk A, Rush ET, Shoback DM, Ward LM, Polgreen LE. PMID: 28655174.
      View in: PubMed   Mentions: 87     Fields:    Translation:Humans
    37. Hypoparathyroidism. Nat Rev Dis Primers. 2017 08 31; 3:17055. Mannstadt M, Bilezikian JP, Thakker RV, Hannan FM, Clarke BL, Rejnmark L, Mitchell DM, Vokes TJ, Winer KK, Shoback DM. PMID: 28857066.
      View in: PubMed   Mentions: 62     Fields:    Translation:Humans
    38. Bone Marrow Fat Changes After Gastric Bypass Surgery Are Associated With Loss of Bone Mass. J Bone Miner Res. 2017 Nov; 32(11):2239-2247. Kim TY, Schwartz AV, Li X, Xu K, Black DM, Petrenko DM, Stewart L, Rogers SJ, Posselt AM, Carter JT, Shoback DM, Schafer AL. PMID: 28791737; PMCID: PMC5685913.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    39. Current Assays to Determine Free 25-Hydroxyvitamin D in Serum. J AOAC Int. 2017 Sep 01; 100(5):1323-1327. Malmstroem S, Rejnmark L, Imboden JB, Shoback DM, Bikle DD. PMID: 28492133.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    40. Does parathyroid hormone control bone quality? Endocrine. 2017 04; 56(1):7-9. Shoback D. PMID: 28042646.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    41. Effects of parathyroid hormone rhPTH(1-84) on phosphate homeostasis and vitamin D metabolism in hypoparathyroidism: REPLACE phase 3 study. Endocrine. 2017 Jan; 55(1):273-282. Clarke BL, Vokes TJ, Bilezikian JP, Shoback DM, Lagast H, Mannstadt M. PMID: 27734257; PMCID: PMC5225224.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCTClinical Trials
    42. Osteoporosis Therapy in Postmenopausal Women With High Risk of Fracture. JAMA. 2016 Aug 16; 316(7):715-6. Cappola AR, Shoback DM. PMID: 27533154.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    43. Management of Hypoparathyroidism: Summary Statement and Guidelines. J Clin Endocrinol Metab. 2016 Jun; 101(6):2273-83. Brandi ML, Bilezikian JP, Shoback D, Bouillon R, Clarke BL, Thakker RV, Khan AA, Potts JT. PMID: 26943719.
      View in: PubMed   Mentions: 126     Fields:    Translation:Humans
    44. Presentation of Hypoparathyroidism: Etiologies and Clinical Features. J Clin Endocrinol Metab. 2016 06; 101(6):2300-12. Shoback DM, Bilezikian JP, Costa AG, Dempster D, Dralle H, Khan AA, Peacock M, Raffaelli M, Silva BC, Thakker RV, Vokes T, Bouillon R. PMID: 26943721.
      View in: PubMed   Mentions: 118     Fields:    Translation:Humans
    45. Interplay between CaSR and PTH1R signaling in skeletal development and osteoanabolism. Semin Cell Dev Biol. 2016 Jan; 49:11-23. Santa Maria C, Cheng Z, Li A, Wang J, Shoback D, Tu CL, Chang W. PMID: 26688334; PMCID: PMC4761456.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimalsCells
    46. A Case of Hypercalcemia and Overexpression of CYP27B1 in Skeletal Muscle Lesions in a Patient with HIV Infection After Cosmetic Injections with Polymethylmethacrylate (PMMA) for Wasting. Calcif Tissue Int. 2015 Dec; 97(6):634-9. Hindi SM, Wang Y, Jones KD, Nussbaum JC, Chang Y, Masharani U, Bikle D, Shoback DM, Hsiao EC. PMID: 26253396; PMCID: PMC4861400.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    47. European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyroidism in adults. Eur J Endocrinol. 2015 Aug; 173(2):G1-20. Bollerslev J, Rejnmark L, Marcocci C, Shoback DM, Sitges-Serra A, van Biesen W, Dekkers OM, European Society of Endocrinology. PMID: 26160136.
      View in: PubMed   Mentions: 138     Fields:    Translation:Humans
    48. Maternal Hypercalcemia Due to Failure of 1,25-Dihydroxyvitamin-D3 Catabolism in a Patient With CYP24A1 Mutations. J Clin Endocrinol Metab. 2015 Aug; 100(8):2832-6. Shah AD, Hsiao EC, O'Donnell B, Salmeen K, Nussbaum R, Krebs M, Baumgartner-Parzer S, Kaufmann M, Jones G, Bikle DD, Wang Y, Mathew AS, Shoback D, Block-Kurbisch I. PMID: 26097993; PMCID: PMC4524985.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    49. Sclerostin inhibition: a novel therapeutic approach in the treatment of osteoporosis. Int J Womens Health. 2015; 7:565-80. Shah AD, Shoback D, Lewiecki EM. PMID: 26082665; PMCID: PMC4459616.
      View in: PubMed   Mentions: 24  
    50. Intestinal Calcium Absorption Decreases Dramatically After Gastric Bypass Surgery Despite Optimization of Vitamin D Status. J Bone Miner Res. 2015 Aug; 30(8):1377-85. Schafer AL, Weaver CM, Black DM, Wheeler AL, Chang H, Szefc GV, Stewart L, Rogers SJ, Carter JT, Posselt AM, Shoback DM, Sellmeyer DE. PMID: 25640580; PMCID: PMC4593653.
      View in: PubMed   Mentions: 65     Fields:    Translation:HumansCTClinical Trials
    51. Changes in vertebral bone marrow fat and bone mass after gastric bypass surgery: A pilot study. Bone. 2015 May; 74:140-5. Schafer AL, Li X, Schwartz AV, Tufts LS, Wheeler AL, Grunfeld C, Stewart L, Rogers SJ, Carter JT, Posselt AM, Black DM, Shoback DM. PMID: 25603463; PMCID: PMC4355193.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCTClinical Trials
    52. Bone Mineral Density, Bone Turnover, and Systemic Inflammation in Non-cirrhotics with Chronic Hepatitis C. Dig Dis Sci. 2015 Jun; 60(6):1813-9. Lai JC, Shoback DM, Zipperstein J, Lizaola B, Tseng S, Terrault NA. PMID: 25563723; PMCID: PMC4797945.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    53. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab. 2014 Oct; 99(10):3570-9. Eastell R, Brandi ML, Costa AG, D'Amour P, Shoback DM, Thakker RV. PMID: 25162666.
      View in: PubMed   Mentions: 121     Fields:    Translation:Humans
    54. Medical management of primary hyperparathyroidism: proceedings of the fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism. J Clin Endocrinol Metab. 2014 Oct; 99(10):3607-18. Marcocci C, Bollerslev J, Khan AA, Shoback DM. PMID: 25162668.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    55. Panostotic expansile bone disease with massive jaw tumor formation and a novel mutation in the signal peptide of RANK. J Bone Miner Res. 2014 Apr; 29(4):911-21. Schafer AL, Mumm S, El-Sayed I, McAlister WH, Horvai AE, Tom AM, Hsiao EC, Schaefer FV, Collins MT, Anderson MS, Whyte MP, Shoback DM. PMID: 24014458; PMCID: PMC4419358.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    56. Gastric bypass in obese rats causes bone loss, vitamin D deficiency, metabolic acidosis, and elevated peptide YY. Surg Obes Relat Dis. 2014 Sep-Oct; 10(5):878-84. Canales BK, Schafer AL, Shoback DM, Carpenter TO. PMID: 24969093; PMCID: PMC4113565.
      View in: PubMed   Mentions: 19     Fields:    Translation:Animals
    57. Rescue of a primary myelofibrosis model by retinoid-antagonist therapy. Proc Natl Acad Sci U S A. 2013 Nov 19; 110(47):18820-5. Hong SH, Dvorak-Ewell M, Stevens HY, Barish GD, Castro GL, Nofsinger R, Frangos JA, Shoback D, Evans RM. PMID: 24191050; PMCID: PMC3839709.
      View in: PubMed   Mentions: 11     Fields:    Translation:AnimalsCells
    58. Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study. Lancet Diabetes Endocrinol. 2013 Dec; 1(4):275-83. Mannstadt M, Clarke BL, Vokes T, Brandi ML, Ranganath L, Fraser WD, Lakatos P, Bajnok L, Garceau R, Mosekilde L, Lagast H, Shoback D, Bilezikian JP. PMID: 24622413.
      View in: PubMed   Mentions: 92     Fields:    Translation:HumansCTClinical Trials
    59. Sex and age modify biochemical and skeletal manifestations of chronic hyperparathyroidism by altering target organ responses to Ca2+ and parathyroid hormone in mice. J Bone Miner Res. 2013 May; 28(5):1087-100. Cheng Z, Liang N, Chen TH, Li A, Santa Maria C, You M, Ho H, Song F, Bikle D, Tu C, Shoback D, Chang W. PMID: 23239173; PMCID: PMC3617088.
      View in: PubMed   Mentions: 16     Fields:    Translation:Animals
    60. Postmenopausal women treated with combination parathyroid hormone (1-84) and ibandronate demonstrate different microstructural changes at the radius vs. tibia: the PTH and Ibandronate Combination Study (PICS). Osteoporos Int. 2013 Oct; 24(10):2591-601. Schafer AL, Burghardt AJ, Sellmeyer DE, Palermo L, Shoback DM, Majumdar S, Black DM. PMID: 23589163.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    61. Calcimimetic and calcilytic drugs for treating bone and mineral-related disorders. Best Pract Res Clin Endocrinol Metab. 2013 Jun; 27(3):373-84. Nemeth EF, Shoback D. PMID: 23856266.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    62. Severe hypercalcemic hyperparathyroidism developing in a patient with hyperaldosteronism and renal resistance to parathyroid hormone. J Bone Miner Res. 2013 Mar; 28(3):700-8. Park-Sigal J, Don BR, Porzig A, Recker R, Griswold V, Sebastian A, Duh QY, Portale AA, Shoback D, Schambelan M. PMID: 23074096.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    63. Six months of parathyroid Hormone (1-84) administered concurrently versus sequentially with monthly ibandronate over two years: the PTH and ibandronate combination study (PICS) randomized trial. J Clin Endocrinol Metab. 2012 Oct; 97(10):3522-9. Schafer AL, Sellmeyer DE, Palermo L, Hietpas J, Eastell R, Shoback DM, Black DM. PMID: 22791766; PMCID: PMC3674294.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    64. Benefits and risks of bisphosphonate therapy for osteoporosis. J Clin Endocrinol Metab. 2012 Jul; 97(7):2272-82. Khosla S, Bilezikian JP, Dempster DW, Lewiecki EM, Miller PD, Neer RM, Recker RR, Shane E, Shoback D, Potts JT. PMID: 22523337.
      View in: PubMed   Mentions: 103     Fields:    Translation:Humans
    65. Osteoblast extracellular Ca2+ -sensing receptor regulates bone development, mineralization, and turnover. J Bone Miner Res. 2011 Dec; 26(12):2935-47. Dvorak-Ewell MM, Chen TH, Liang N, Garvey C, Liu B, Tu C, Chang W, Bikle DD, Shoback DM. PMID: 21956637; PMCID: PMC3222747.
      View in: PubMed   Mentions: 33     Fields:    Translation:AnimalsCells
    66. Progressive craniofacial bone loss after cosmetic surgery at the forehead. Skeletal Radiol. 2012 Apr; 41(4):477-81. Prasad AP, George V, Porzig A, Horvai AE, Gross A, Shoback D, Link TM. PMID: 22127344.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    67. Change in undercarboxylated osteocalcin is associated with changes in body weight, fat mass, and adiponectin: parathyroid hormone (1-84) or alendronate therapy in postmenopausal women with osteoporosis (the PaTH study). J Clin Endocrinol Metab. 2011 Dec; 96(12):E1982-9. Schafer AL, Sellmeyer DE, Schwartz AV, Rosen CJ, Vittinghoff E, Palermo L, Bilezikian JP, Shoback DM, Black DM. PMID: 21994958; PMCID: PMC3232610.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    68. Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J Bone Miner Res. 2011 Oct; 26(10):2317-37. Bilezikian JP, Khan A, Potts JT, Brandi ML, Clarke BL, Shoback D, Jüppner H, D'Amour P, Fox J, Rejnmark L, Mosekilde L, Rubin MR, Dempster D, Gafni R, Collins MT, Sliney J, Sanders J. PMID: 21812031; PMCID: PMC3405491.
      View in: PubMed   Mentions: 193     Fields:    Translation:Humans
    69. Cinacalcet HCl reduces hypercalcemia in primary hyperparathyroidism across a wide spectrum of disease severity. J Clin Endocrinol Metab. 2011 Jan; 96(1):E9-18. Peacock M, Bilezikian JP, Bolognese MA, Borofsky M, Scumpia S, Sterling LR, Cheng S, Shoback D. PMID: 20943783; PMCID: PMC3203649.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCTClinical Trials
    70. Naturally-occurring mutation in the calcium-sensing receptor reveals the significance of extracellular domain loop III region for class C G-protein-coupled receptor function. J Clin Endocrinol Metab. 2010 Oct; 95(10):E245-52. Dong Q, Cheng Z, Chang W, Blackman BE, Conte FA, Hu J, Shoback D, Miller WL. PMID: 20631026; PMCID: PMC3050095.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    71. Assessing constitutive activity of extracellular calcium-sensing receptors in vitro and in bone. Methods Enzymol. 2010; 484:253-66. Chang W, Dvorak M, Shoback D. PMID: 21036236; PMCID: PMC3528079.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    72. Cinacalcet treatment of primary hyperparathyroidism: biochemical and bone densitometric outcomes in a five-year study. J Clin Endocrinol Metab. 2009 Dec; 94(12):4860-7. Peacock M, Bolognese MA, Borofsky M, Scumpia S, Sterling LR, Cheng S, Shoback D. PMID: 19837909.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    73. Hypercalcemia and overexpression of CYP27B1 in a patient with nephrogenic systemic fibrosis: clinical vignette and literature review. J Bone Miner Res. 2009 Jun; 24(6):1135-9. Pao VY, Chang S, Shoback DM, Bikle DD. PMID: 19113910; PMCID: PMC6956690.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    74. Cinacalcet reduces serum calcium concentrations in patients with intractable primary hyperparathyroidism. J Clin Endocrinol Metab. 2009 Aug; 94(8):2766-72. Marcocci C, Chanson P, Shoback D, Bilezikian J, Fernandez-Cruz L, Orgiazzi J, Henzen C, Cheng S, Sterling LR, Lu J, Peacock M. PMID: 19470620; PMCID: PMC3214593.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    75. Medical management of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab. 2009 Feb; 94(2):373-81. Khan A, Grey A, Shoback D. PMID: 19193912.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    76. The extracellular calcium-sensing receptor (CaSR) is a critical modulator of skeletal development. Sci Signal. 2008 Sep 02; 1(35):ra1. Chang W, Tu C, Chen TH, Bikle D, Shoback D. PMID: 18765830; PMCID: PMC3538864.
      View in: PubMed   Mentions: 109     Fields:    Translation:HumansAnimalsCells
    77. Clinical practice. Hypoparathyroidism. N Engl J Med. 2008 Jul 24; 359(4):391-403. Shoback D. PMID: 18650515.
      View in: PubMed   Mentions: 183     Fields:    Translation:Humans
    78. Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma. J Clin Endocrinol Metab. 2007 Oct; 92(10):3803-8. Silverberg SJ, Rubin MR, Faiman C, Peacock M, Shoback DM, Smallridge RC, Schwanauer LE, Olson KA, Klassen P, Bilezikian JP. PMID: 17666472.
      View in: PubMed   Mentions: 65     Fields:    Translation:HumansCTClinical Trials
    79. Type B gamma-aminobutyric acid receptors modulate the function of the extracellular Ca2+-sensing receptor and cell differentiation in murine growth plate chondrocytes. Endocrinology. 2007 Oct; 148(10):4984-92. Cheng Z, Tu C, Rodriguez L, Chen TH, Dvorak MM, Margeta M, Gassmann M, Bettler B, Shoback D, Chang W. PMID: 17615148.
      View in: PubMed   Mentions: 21     Fields:    Translation:AnimalsCells
    80. Complex formation with the Type B gamma-aminobutyric acid receptor affects the expression and signal transduction of the extracellular calcium-sensing receptor. Studies with HEK-293 cells and neurons. J Biol Chem. 2007 Aug 24; 282(34):25030-40. Chang W, Tu C, Cheng Z, Rodriguez L, Chen TH, Gassmann M, Bettler B, Margeta M, Jan LY, Shoback D. PMID: 17591780.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansAnimalsCells
    81. Constitutive activity of the osteoblast Ca2+-sensing receptor promotes loss of cancellous bone. Endocrinology. 2007 Jul; 148(7):3156-63. Dvorak MM, Chen TH, Orwoll B, Garvey C, Chang W, Bikle DD, Shoback DM. PMID: 17412806.
      View in: PubMed   Mentions: 30     Fields:    Translation:AnimalsCells
    82. Update in osteoporosis and metabolic bone disorders. J Clin Endocrinol Metab. 2007 Mar; 92(3):747-53. Shoback D. PMID: 17341572.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansAnimals
    83. WITHDRAWN: Type B gamma-aminobutyric Acid Receptors Modulate the Expression and Function of the Extracellular Ca2+-sensing Receptor in Murine Growth Plate Chondrocytes. Endocrinology. 2006 Sep 05. Cheng Z, Tu C, Rodriguez L, Dvorak MM, Margeta M, Gassmann M, Bettler B, Shoback D, Chang W. PMID: 16728489.
      View in: PubMed   Mentions:    Fields:    
    84. Expression and functional assessment of an alternatively spliced extracellular Ca2+-sensing receptor in growth plate chondrocytes. Endocrinology. 2005 Dec; 146(12):5294-303. Rodriguez L, Tu C, Cheng Z, Chen TH, Bikle D, Shoback D, Chang W. PMID: 16166224.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
    85. Extracellular Ca2+-sensing in cartilage. J Musculoskelet Neuronal Interact. 2004 Dec; 4(4):410-1. Chang W, Rodriguez L, Chen TH, Tu C, Shoback D. PMID: 15758285.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    86. Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism. J Clin Endocrinol Metab. 2005 Jan; 90(1):135-41. Peacock M, Bilezikian JP, Klassen PS, Guo MD, Turner SA, Shoback D. PMID: 15522938.
      View in: PubMed   Mentions: 85     Fields:    Translation:HumansCTClinical Trials
    87. cDNA cloning and functional expression of a Ca2+-sensing receptor with truncated C-terminal tail from the Mozambique tilapia (Oreochromis mossambicus). J Biol Chem. 2004 Dec 17; 279(51):53288-97. Loretz CA, Pollina C, Hyodo S, Takei Y, Chang W, Shoback D. PMID: 15456780.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    88. Fanconi's syndrome in HIV+ adults: report of three cases and literature review. J Bone Miner Res. 2004 May; 19(5):714-21. Earle KE, Seneviratne T, Shaker J, Shoback D. PMID: 15068493.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    89. Extracellular Ca2+-sensing receptors--an overview. Cell Calcium. 2004 Mar; 35(3):183-96. Chang W, Shoback D. PMID: 15200142.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimalsCells
    90. The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism. J Clin Endocrinol Metab. 2003 Dec; 88(12):5644-9. Shoback DM, Bilezikian JP, Turner SA, McCary LC, Guo MD, Peacock M. PMID: 14671147.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansCTClinical Trials
    91. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med. 2003 Oct 30; 349(18):1722-9. Shattuck TM, Välimäki S, Obara T, Gaz RD, Clark OH, Shoback D, Wierman ME, Tojo K, Robbins CM, Carpten JD, Farnebo LO, Larsson C, Arnold A. PMID: 14585940.
      View in: PubMed   Mentions: 178     Fields:    Translation:Humans
    92. Mutational analyses of RB and BRCA2 as candidate tumour suppressor genes in parathyroid carcinoma. Clin Endocrinol (Oxf). 2003 Aug; 59(2):180-9. Shattuck TM, Kim TS, Costa J, Yandell DW, Imanishi Y, Palanisamy N, Gaz RD, Shoback D, Clark OH, Monchik JM, Wierman ME, Hollenberg A, Tojo K, Chaganti RS, Arnold A. PMID: 12864795.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    93. Calcimimetics in the treatment of primary hyperparathyroidism. J Bone Miner Res. 2002 Nov; 17 Suppl 2:N141-5. Antoniucci DM, Shoback D. PMID: 12412791.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    94. Extracellular Ca(2+)-sensing receptors modulate matrix production and mineralization in chondrogenic RCJ3.1C5.18 cells. Endocrinology. 2002 Apr; 143(4):1467-74. Chang W, Tu C, Pratt S, Chen TH, Shoback D. PMID: 11897705.
      View in: PubMed   Mentions: 23     Fields:    Translation:AnimalsCells
    95. Amino acids in the cytoplasmic C terminus of the parathyroid Ca2+-sensing receptor mediate efficient cell-surface expression and phospholipase C activation. J Biol Chem. 2001 Nov 23; 276(47):44129-36. Chang W, Pratt S, Chen TH, Bourguignon L, Shoback D. PMID: 11535593.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    96. Starvation amidst plenty--rickets and hypercalcemia in calcium receptor knockout mice. Endocrinology. 2001 Sep; 142(9):3733-5. Shoback D, Chang W. PMID: 11517147.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    97. Parathyroid cells express dihydropyridine-sensitive cation currents and L-type calcium channel subunits. Am J Physiol Endocrinol Metab. 2001 Jul; 281(1):E180-9. Chang W, Pratt SA, Chen TH, Tu CL, Mikala G, Schwartz A, Shoback D. PMID: 11404236.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    98. Analysis of inositol phospholipid turnover during lymphocyte activation. Curr Protoc Immunol. 2001 May; Chapter 11:Unit 11.1. Imboden JB, Shoback DM, Inokuchi S. PMID: 18432702.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    99. Amino acids in the second and third intracellular loops of the parathyroid Ca2+-sensing receptor mediate efficient coupling to phospholipase C. J Biol Chem. 2000 Jun 30; 275(26):19955-63. Chang W, Chen TH, Pratt S, Shoback D. PMID: 10764812.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimalsCells
    100. Paget's disease of bone: diagnosis and treatment update. Curr Rheumatol Rep. 2000 Feb; 2(1):67-73. Noor M, Shoback D. PMID: 11123042.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    101. Protein kinase C activation blocks calcium receptor signaling in Xenopus laevis oocytes. Mol Cell Endocrinol. 1999 Dec 20; 158(1-2):13-23. Chang W, Pratt S, Chen TH, Shoback D. PMID: 10630401.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    102. Expression and signal transduction of calcium-sensing receptors in cartilage and bone. Endocrinology. 1999 Dec; 140(12):5883-93. Chang W, Tu C, Chen TH, Komuves L, Oda Y, Pratt SA, Miller S, Shoback D. PMID: 10579354.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansAnimalsCells
    103. Calcium sensing in cultured chondrogenic RCJ3.1C5.18 cells. Endocrinology. 1999 Apr; 140(4):1911-9. Chang W, Tu C, Bajra R, Komuves L, Miller S, Strewler G, Shoback D. PMID: 10098531.
      View in: PubMed   Mentions: 18     Fields:    Translation:AnimalsCells
    104. Clinical effects of raloxifene hydrochloride in women. Ann Intern Med. 1999 Mar 02; 130(5):431-9. Khovidhunkit W, Shoback DM. PMID: 10068418.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimalsCells
    105. Regulation of extracellular calcium-activated cation currents by cAMP in parathyroid cells. Am J Physiol. 1998 08; 275(2):E213-21. Chang W, Chen TH, Pratt S, Shoback D. PMID: 9688621.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    106. Coupling of calcium receptors to inositol phosphate and cyclic AMP generation in mammalian cells and Xenopus laevis oocytes and immunodetection of receptor protein by region-specific antipeptide antisera. J Bone Miner Res. 1998 Apr; 13(4):570-80. Chang W, Pratt S, Chen TH, Nemeth E, Huang Z, Shoback D. PMID: 9556057.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimalsCells
    107. Clinical profile of primary hyperparathyroidism in adolescents and young adults. Clin Endocrinol (Oxf). 1998 Apr; 48(4):435-43. Loh KC, Duh QY, Shoback D, Gee L, Siperstein A, Clark OH. PMID: 9640410.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    108. Hypercalcemia in malignant paraganglioma due to parathyroid hormone-related protein. Horm Res. 1998; 50(4):217-21. Loh K, Matthay KK, Hoover M, Bracho FA, Cortez AB, Conte FA, Albanese CT, Miller TR, Price DC, Flores AJ, Kaviani A, Shoback D. PMID: 9838243.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    109. Parathyroid Ca(2+)-conducting currents are modulated by muscarinic receptor agonists and antagonists. Am J Physiol. 1997 11; 273(5):E880-90. Chang W, Chen TH, Pratt SA, Yen B, Fu M, Shoback D. PMID: 9374672.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    110. The N-terminal region of the third intracellular loop of the parathyroid hormone (PTH)/PTH-related peptide receptor is critical for coupling to cAMP and inositol phosphate/Ca2+ signal transduction pathways. J Biol Chem. 1996 Dec 27; 271(52):33382-9. Huang Z, Chen Y, Pratt S, Chen TH, Bambino T, Nissenson RA, Shoback DM. PMID: 8969199.
      View in: PubMed   Mentions: 11     Fields:    Translation:AnimalsCells
    111. Regulation of Ca(2+)-conducting currents in parathyroid cells by extracellular Ca(2+) and channel blockers. Am J Physiol. 1995 Nov; 269(5 Pt 1):E864-77. Chang W, Chen TH, Gardner P, Shoback D. PMID: 7491938.
      View in: PubMed   Mentions: 6     Fields:    Translation:AnimalsCells
    112. Mutational analysis of the cytoplasmic tail of the G protein-coupled receptor for parathyroid hormone (PTH) and PTH-related protein: effects on receptor expression and signaling. Mol Endocrinol. 1995 Sep; 9(9):1240-9. Huang Z, Chen Y, Pratt S, Chen TH, Bambino T, Shoback DM, Nissenson RA. PMID: 7491116.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    113. Transient osteoporosis of the hip in pregnancy: natural history of changes in bone mineral density. Clin Endocrinol (Oxf). 1995 Sep; 43(3):373-82. Funk JL, Shoback DM, Genant HK. PMID: 7586609.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    114. Thapsigargin stimulates intracellular calcium mobilization and inhibits parathyroid hormone release. J Bone Miner Res. 1995 May; 10(5):743-50. Shoback D, Chen TH, Pratt S, Lattyak B. PMID: 7639110.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    115. Injection of bovine parathyroid poly(A)+ RNA into Xenopus oocytes confers sensitivity to high extracellular calcium. J Bone Miner Res. 1994 Feb; 9(2):293-300. Chen TH, Pratt SA, Shoback DM. PMID: 7511319.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    116. Effects of high extracellular calcium and strontium on inositol polyphosphates in bovine parathyroid cells. J Bone Miner Res. 1993 Jul; 8(7):891-8. Shoback DM, Chen TH, Lattyak B, King K, Johnson RM. PMID: 8352071.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    117. Structure and function of the receptor for parathyroid hormone and parathyroid hormone-related protein. Receptor. 1993; 3(3):193-202. Nissenson RA, Huang Z, Blind E, Shoback D. PMID: 8167570.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    118. Effects of protein kinase C activation on inositol phosphate generation and intracellular Ca2+ mobilization in bovine parathyroid cells. Endocrinology. 1990 Jul; 127(1):141-8. Shoback DM, Chen TH. PMID: 2361470.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    119. Effects of phosphatidic acid on parathyroid hormone release, intracellular free Ca2+, and inositol phosphates in dispersed bovine parathyroid cells. Endocrinology. 1990 Feb; 126(2):899-907. McGhee JG, Shoback DM. PMID: 2153532.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    120. The effects of protein kinase-C agonists on parathyroid hormone release and intracellular free Ca2+ in bovine parathyroid cells. Endocrinology. 1989 Feb; 124(2):789-97. Membreño L, Chen TH, Woodley S, Gagucas R, Shoback D. PMID: 2536321.
      View in: PubMed   Mentions: 6     Fields:    Translation:AnimalsCells
    121. High calcium and other divalent cations increase inositol trisphosphate in bovine parathyroid cells. Endocrinology. 1988 Jul; 123(1):382-9. Shoback DM, Membreno LA, McGhee JG. PMID: 3260174.
      View in: PubMed   Mentions: 13     Fields:    Translation:AnimalsCells
    122. Fluoride stimulates the accumulation of inositol phosphates, increases intracellular free calcium, and inhibits parathyroid hormone release in dispersed bovine parathyroid cells. Endocrinology. 1988 Jun; 122(6):2833-9. Shoback DM, McGhee JM. PMID: 2836175.
      View in: PubMed   Mentions: 5     Fields:    Translation:Animals
    123. Reverse T3 and modulators of the calcium messenger system rapidly decrease T4-5'-deiodinase II activity in cultured mouse neuroblastoma cells. Thyroidology. 1988 Apr; (1):5-12. Gavin LA, Moeller M, Shoback D, Cavalieri RR. PMID: 2484895.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    124. Renin suppression by saline is blunted in nonmodulating essential hypertension. Hypertension. 1987 Oct; 10(4):404-8. Rabinowe SL, Redgrave JE, Shoback DM, Podolsky S, Hollenberg NK, Williams GH. PMID: 3308701.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    125. Ouabain and low extracellular potassium inhibit PTH secretion from bovine parathyroid cells by a mechanism that does not involve increases in the cytosolic calcium concentration. Metabolism. 1987 Jan; 36(1):36-42. Brown EM, Watson EJ, Thatcher JG, Koletsky R, Dawson-Hughes BF, Posillico JT, Shoback DM. PMID: 3025550.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    126. Abnormal renal sodium handling in essential hypertension. Relation to failure of renal and adrenal modulation of responses to angiotensin II. Am J Med. 1986 Sep; 81(3):412-8. Hollenberg NK, Moore T, Shoback D, Redgrave J, Rabinowe S, Williams GH. PMID: 3752141.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    127. Cholera toxin inhibits the T-cell antigen receptor-mediated increases in inositol trisphosphate and cytoplasmic free calcium. Proc Natl Acad Sci U S A. 1986 Aug; 83(15):5673-7. Imboden JB, Shoback DM, Pattison G, Stobo JD. PMID: 3016713; PMCID: PMC386351.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansCells
    128. Regulation of parathyroid hormone release and cytosolic calcium by extracellular calcium in dispersed and cultured bovine and pathological human parathyroid cells. J Clin Invest. 1985 Jan; 75(1):49-57. LeBoff MS, Shoback D, Brown EM, Thatcher J, Leombruno R, Beaudoin D, Henry M, Wilson R, Pallotta J, Marynick S, et al. PMID: 3965511; PMCID: PMC423397.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimalsCells
    129. Interaction of extracellular calcium and magnesium in the regulation of cytosolic calcium and PTH release in dispersed bovine parathyroid cells. Mol Cell Endocrinol. 1984 Dec; 38(2-3):179-86. Shoback DM, Thatcher JG, Brown EM. PMID: 6510551.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    130. PTH release stimulated by high extracellular potassium is associated with a decrease in cytosolic calcium in bovine parathyroid cells. Biochem Biophys Res Commun. 1984 Sep 17; 123(2):684-90. Shoback DM, Brown EM. PMID: 6487306.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    131. Role of T3 surface molecules in human T-cell activation: T3-dependent activation results in an increase in cytoplasmic free calcium. Proc Natl Acad Sci U S A. 1984 Jul; 81(13):4169-73. Weiss A, Imboden J, Shoback D, Stobo J. PMID: 6234599; PMCID: PMC345390.
      View in: PubMed   Mentions: 120     Fields:    Translation:HumansAnimalsCells
    132. Forskolin increases cellular cyclic adenosine monophosphate content and parathyroid hormone release in dispersed bovine parathyroid cells. Metabolism. 1984 Jun; 33(6):509-14. Shoback DM, Brown EM. PMID: 6328173.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    133. Relationship between parathyroid hormone secretion and cytosolic calcium concentration in dispersed bovine parathyroid cells. Proc Natl Acad Sci U S A. 1984 May; 81(10):3113-7. Shoback DM, Thatcher J, Leombruno R, Brown EM. PMID: 6328497; PMCID: PMC345231.
      View in: PubMed   Mentions: 17     Fields:    Translation:AnimalsCells
    134. The relationship between PTH secretion and cytosolic calcium concentration in bovine parathyroid cells. Prog Clin Biol Res. 1984; 168:139-44. Brown EM, Shoback DM. PMID: 6096881.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    135. Defect in the sodium-modulated tissue responsiveness to angiotensin II in essential hypertension. J Clin Invest. 1983 Dec; 72(6):2115-24. Shoback DM, Williams GH, Moore TJ, Dluhy RG, Podolsky S, Hollenberg NK. PMID: 6358261; PMCID: PMC437052.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    136. Time course and effect of sodium intake on vascular and hormonal responses to enalapril (MK 421) in normal subjects. J Cardiovasc Pharmacol. 1983 Nov-Dec; 5(6):1010-8. Shoback DM, Williams GH, Swartz SL, Davies RO, Hollenberg NK. PMID: 6196548.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    137. Endogenous angiotensin II as a determinant of sodium-modulated changes in tissue responsiveness to angiotensin II in normal man. J Clin Endocrinol Metab. 1983 Oct; 57(4):764-70. Shoback DM, Williams GH, Hollenberg NK, Davies RO, Moore TJ, Dluhy RG. PMID: 6309884.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    138. Phaeochromocytoma and hypertrophic cardiomyopathy: apparent suppression of symptoms and noradrenaline secretion by calcium-channel blockade. Lancet. 1983 Sep 24; 2(8352):711-3. Serfas D, Shoback DM, Lorell BH. PMID: 6136843.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    139. Effects of extracellular Ca++ and Mg++ on cytosolic Ca++ and PTH release in dispersed bovine parathyroid cells. Endocrinology. 1983 Jul; 113(1):424-6. Shoback D, Thatcher J, Leombruno R, Brown E. PMID: 6861713.
      View in: PubMed   Mentions: 21     Fields:    Translation:AnimalsCells
    140. Delayed acute myocardial infarction after blunt chest trauma in a young woman. Am Heart J. 1980 Dec; 100(6 Pt 1):907-16. Vlay SC, Blumenthal DS, Shoback D, Fehir K, Bulkley BH. PMID: 7446393.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    141. Familial cryoglobulinemia. Johns Hopkins Med J. 1977 May; 140(5):267-74. Shoback D. PMID: 859235.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    142. Clinical-pathological conference. Johns Hopkins Med J. 1977 Apr; 140(4):193-205. Shoback D, Kan JA. PMID: 850338.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    143. Pheochromocytoma. Johns Hopkins Med J. 1976 Sep; 139(3):131-7. Shoback D. PMID: 972438.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    Dolores's Networks
    Concepts (519)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (60)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.